Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/s42003-021-01666-5.

Title:
Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition | Communications Biology
Description:
The structural mechanisms of single-pass transmembrane enzymes remain elusive. Kynurenine 3-monooxygenase (KMO) is a mitochondrial protein involved in the eukaryotic tryptophan catabolic pathway and is linked to various diseases. Here, we report the mammalian full-length structure of KMO in its membrane-embedded form, complexed with compound 3 (identified internally) and compound 4 (identified via DNA-encoded chemical library screening) at 3.0 Å resolution. Despite predictions suggesting that KMO has two transmembrane domains, we show that KMO is actually a single-pass transmembrane protein, with the other transmembrane domain lying laterally along the membrane, where it forms part of the ligand-binding pocket. Further exploration of compound 3 led to identification of the brain-penetrant compound, 5. We show that KMO is dimeric, and that mutations at the dimeric interface abolish its activity. These results will provide insight for the drug discovery of additional blood-brain-barrier molecules, and help illuminate the complex biology behind single-pass transmembrane enzymes. Mimasu et al. report a rat full-length structure of kynurenine 3-monooxygenase (KMO) in its membrane-embedded form, complexed with two inhibitors. They find that the dimeric interface of KMO is critical for its activity. This study provides insights into the drug development strategies that target KMO, an important regulator of tryptophan metabolism.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Science
  • Technology & Computing

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 41,362,249 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$521,200 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $347,485 to $955,583.

Keywords {🔍}

kmo, compound, article, ratkmo, pubmed, kynurenine, google, scholar, cas, structure, fig, supplementary, data, monooxygenase, assay, nature, pocket, determined, site, studies, residues, assays, compounds, binding, buffer, activity, structures, central, fulllength, human, inhibitors, performed, table, inhibition, region, observed, structural, protein, membrane, hskmo, information, rat, domain, group, hydrophobic, biol, transmembrane, pathway, substrate, cells,

Topics {✒️}

nature portfolio privacy policy x-ray diffraction experiments editing mammalian nature full-length rat-kmo-expressing membranes 5% n-dodecyl β-d-maltoside 012% n-dodecyl β-d-maltoside advertising additional blood-brain-barrier molecules β-sheet-disrupting y185p mutation nature 496 nature 532 nature tsukuba research centre scientific advice social media discussion structure-activity relationships gst-tagged full-length kmo reprints huntington’s-disease-relevant phenotypes10 research design purified full-length rat-kmo full-length rat-kmo purified poly-d-lysine-coated 384 automatic data-collection system formic acid/water/acetonitrile/methanol β-sheet dimer interface nhs/edc amine coupling references mole renal ischemia-reperfusion injury astellas/x-chem collaboration single-pass transmembrane enzymes single-pass membrane enzymes30 single-pass membrane receptors research high-throughput structure analysis bio-beads sm-2 adsorbents structural mechanisms single-pass transmembrane protein full-length rattus norvegicus full-length rat-kmo rat-kmo monomer consists data availability kdm6a-dependent upregulation blood ameliorates neurodegeneration nanobret nano-glo substrate 100 μg/ml flag peptide mammalian full-length structure elusive structure-function relationship

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition
         description:The structural mechanisms of single-pass transmembrane enzymes remain elusive. Kynurenine 3-monooxygenase (KMO) is a mitochondrial protein involved in the eukaryotic tryptophan catabolic pathway and is linked to various diseases. Here, we report the mammalian full-length structure of KMO in its membrane-embedded form, complexed with compound 3 (identified internally) and compound 4 (identified via DNA-encoded chemical library screening) at 3.0 Å resolution. Despite predictions suggesting that KMO has two transmembrane domains, we show that KMO is actually a single-pass transmembrane protein, with the other transmembrane domain lying laterally along the membrane, where it forms part of the ligand-binding pocket. Further exploration of compound 3 led to identification of the brain-penetrant compound, 5. We show that KMO is dimeric, and that mutations at the dimeric interface abolish its activity. These results will provide insight for the drug discovery of additional blood-brain-barrier molecules, and help illuminate the complex biology behind single-pass transmembrane enzymes. Mimasu et al. report a rat full-length structure of kynurenine 3-monooxygenase (KMO) in its membrane-embedded form, complexed with two inhibitors. They find that the dimeric interface of KMO is critical for its activity. This study provides insights into the drug development strategies that target KMO, an important regulator of tryptophan metabolism.
         datePublished:2021-02-04T00:00:00Z
         dateModified:2021-02-04T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s42003-021-01666-5
         keywords:
            Enzyme mechanisms
            Neurodegeneration
            Pharmacology
            X-ray crystallography
            Life Sciences
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42003-021-01666-5/MediaObjects/42003_2021_1666_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42003-021-01666-5/MediaObjects/42003_2021_1666_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42003-021-01666-5/MediaObjects/42003_2021_1666_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42003-021-01666-5/MediaObjects/42003_2021_1666_Fig4_HTML.png
         isPartOf:
            name:Communications Biology
            issn:
               2399-3642
            volumeNumber:4
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Shinya Mimasu
               url:http://orcid.org/0000-0002-5061-9587
               affiliation:
                     name:Astellas Pharma. Inc.
                     address:
                        name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Hiroaki Yamagishi
               affiliation:
                     name:Astellas Pharma. Inc.
                     address:
                        name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                        type:PostalAddress
                     type:Organization
                     name:Idemitsu Kosan Co., Ltd.
                     address:
                        name:Electronic Materials Department, Idemitsu Kosan Co., Ltd., Sodegaura, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Satoshi Kubo
               affiliation:
                     name:Astellas Pharma. Inc.
                     address:
                        name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mie Kiyohara
               affiliation:
                     name:Astellas Pharma. Inc.
                     address:
                        name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Toshihiro Matsuda
               affiliation:
                     name:Astellas Pharma. Inc.
                     address:
                        name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Toshiko Yahata
               affiliation:
                     name:Astellas Pharma. Inc.
                     address:
                        name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Heather A. Thomson
               affiliation:
                     name:X-Chem Inc.
                     address:
                        name:X-Chem Inc., Waltham, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christopher D. Hupp
               affiliation:
                     name:X-Chem Inc.
                     address:
                        name:X-Chem Inc., Waltham, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Julie Liu
               affiliation:
                     name:X-Chem Inc.
                     address:
                        name:X-Chem Inc., Waltham, USA
                        type:PostalAddress
                     type:Organization
                     name:Civetta Therapeutics
                     address:
                        name:Civetta Therapeutics, Cambridge, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Takao Okuda
               affiliation:
                     name:Astellas Pharma. Inc.
                     address:
                        name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                        type:PostalAddress
                     type:Organization
                     name:Nemoto Science Co., Ltd
                     address:
                        name:Formulation, Tsukuba Laboratory, Nemoto Science Co., Ltd, Joso-shi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kenichi Kakefuda
               affiliation:
                     name:Astellas Pharma. Inc.
                     address:
                        name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition
      description:The structural mechanisms of single-pass transmembrane enzymes remain elusive. Kynurenine 3-monooxygenase (KMO) is a mitochondrial protein involved in the eukaryotic tryptophan catabolic pathway and is linked to various diseases. Here, we report the mammalian full-length structure of KMO in its membrane-embedded form, complexed with compound 3 (identified internally) and compound 4 (identified via DNA-encoded chemical library screening) at 3.0 Å resolution. Despite predictions suggesting that KMO has two transmembrane domains, we show that KMO is actually a single-pass transmembrane protein, with the other transmembrane domain lying laterally along the membrane, where it forms part of the ligand-binding pocket. Further exploration of compound 3 led to identification of the brain-penetrant compound, 5. We show that KMO is dimeric, and that mutations at the dimeric interface abolish its activity. These results will provide insight for the drug discovery of additional blood-brain-barrier molecules, and help illuminate the complex biology behind single-pass transmembrane enzymes. Mimasu et al. report a rat full-length structure of kynurenine 3-monooxygenase (KMO) in its membrane-embedded form, complexed with two inhibitors. They find that the dimeric interface of KMO is critical for its activity. This study provides insights into the drug development strategies that target KMO, an important regulator of tryptophan metabolism.
      datePublished:2021-02-04T00:00:00Z
      dateModified:2021-02-04T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s42003-021-01666-5
      keywords:
         Enzyme mechanisms
         Neurodegeneration
         Pharmacology
         X-ray crystallography
         Life Sciences
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42003-021-01666-5/MediaObjects/42003_2021_1666_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42003-021-01666-5/MediaObjects/42003_2021_1666_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42003-021-01666-5/MediaObjects/42003_2021_1666_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42003-021-01666-5/MediaObjects/42003_2021_1666_Fig4_HTML.png
      isPartOf:
         name:Communications Biology
         issn:
            2399-3642
         volumeNumber:4
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Shinya Mimasu
            url:http://orcid.org/0000-0002-5061-9587
            affiliation:
                  name:Astellas Pharma. Inc.
                  address:
                     name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Hiroaki Yamagishi
            affiliation:
                  name:Astellas Pharma. Inc.
                  address:
                     name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                     type:PostalAddress
                  type:Organization
                  name:Idemitsu Kosan Co., Ltd.
                  address:
                     name:Electronic Materials Department, Idemitsu Kosan Co., Ltd., Sodegaura, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Satoshi Kubo
            affiliation:
                  name:Astellas Pharma. Inc.
                  address:
                     name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mie Kiyohara
            affiliation:
                  name:Astellas Pharma. Inc.
                  address:
                     name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Toshihiro Matsuda
            affiliation:
                  name:Astellas Pharma. Inc.
                  address:
                     name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Toshiko Yahata
            affiliation:
                  name:Astellas Pharma. Inc.
                  address:
                     name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Heather A. Thomson
            affiliation:
                  name:X-Chem Inc.
                  address:
                     name:X-Chem Inc., Waltham, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christopher D. Hupp
            affiliation:
                  name:X-Chem Inc.
                  address:
                     name:X-Chem Inc., Waltham, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Julie Liu
            affiliation:
                  name:X-Chem Inc.
                  address:
                     name:X-Chem Inc., Waltham, USA
                     type:PostalAddress
                  type:Organization
                  name:Civetta Therapeutics
                  address:
                     name:Civetta Therapeutics, Cambridge, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Takao Okuda
            affiliation:
                  name:Astellas Pharma. Inc.
                  address:
                     name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                     type:PostalAddress
                  type:Organization
                  name:Nemoto Science Co., Ltd
                  address:
                     name:Formulation, Tsukuba Laboratory, Nemoto Science Co., Ltd, Joso-shi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kenichi Kakefuda
            affiliation:
                  name:Astellas Pharma. Inc.
                  address:
                     name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Communications Biology
      issn:
         2399-3642
      volumeNumber:4
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Astellas Pharma. Inc.
      address:
         name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
         type:PostalAddress
      name:Astellas Pharma. Inc.
      address:
         name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
         type:PostalAddress
      name:Idemitsu Kosan Co., Ltd.
      address:
         name:Electronic Materials Department, Idemitsu Kosan Co., Ltd., Sodegaura, Japan
         type:PostalAddress
      name:Astellas Pharma. Inc.
      address:
         name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
         type:PostalAddress
      name:Astellas Pharma. Inc.
      address:
         name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
         type:PostalAddress
      name:Astellas Pharma. Inc.
      address:
         name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
         type:PostalAddress
      name:Astellas Pharma. Inc.
      address:
         name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
         type:PostalAddress
      name:X-Chem Inc.
      address:
         name:X-Chem Inc., Waltham, USA
         type:PostalAddress
      name:X-Chem Inc.
      address:
         name:X-Chem Inc., Waltham, USA
         type:PostalAddress
      name:X-Chem Inc.
      address:
         name:X-Chem Inc., Waltham, USA
         type:PostalAddress
      name:Civetta Therapeutics
      address:
         name:Civetta Therapeutics, Cambridge, USA
         type:PostalAddress
      name:Astellas Pharma. Inc.
      address:
         name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
         type:PostalAddress
      name:Nemoto Science Co., Ltd
      address:
         name:Formulation, Tsukuba Laboratory, Nemoto Science Co., Ltd, Joso-shi, Japan
         type:PostalAddress
      name:Astellas Pharma. Inc.
      address:
         name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Shinya Mimasu
      url:http://orcid.org/0000-0002-5061-9587
      affiliation:
            name:Astellas Pharma. Inc.
            address:
               name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Hiroaki Yamagishi
      affiliation:
            name:Astellas Pharma. Inc.
            address:
               name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
               type:PostalAddress
            type:Organization
            name:Idemitsu Kosan Co., Ltd.
            address:
               name:Electronic Materials Department, Idemitsu Kosan Co., Ltd., Sodegaura, Japan
               type:PostalAddress
            type:Organization
      name:Satoshi Kubo
      affiliation:
            name:Astellas Pharma. Inc.
            address:
               name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
               type:PostalAddress
            type:Organization
      name:Mie Kiyohara
      affiliation:
            name:Astellas Pharma. Inc.
            address:
               name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
               type:PostalAddress
            type:Organization
      name:Toshihiro Matsuda
      affiliation:
            name:Astellas Pharma. Inc.
            address:
               name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
               type:PostalAddress
            type:Organization
      name:Toshiko Yahata
      affiliation:
            name:Astellas Pharma. Inc.
            address:
               name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
               type:PostalAddress
            type:Organization
      name:Heather A. Thomson
      affiliation:
            name:X-Chem Inc.
            address:
               name:X-Chem Inc., Waltham, USA
               type:PostalAddress
            type:Organization
      name:Christopher D. Hupp
      affiliation:
            name:X-Chem Inc.
            address:
               name:X-Chem Inc., Waltham, USA
               type:PostalAddress
            type:Organization
      name:Julie Liu
      affiliation:
            name:X-Chem Inc.
            address:
               name:X-Chem Inc., Waltham, USA
               type:PostalAddress
            type:Organization
            name:Civetta Therapeutics
            address:
               name:Civetta Therapeutics, Cambridge, USA
               type:PostalAddress
            type:Organization
      name:Takao Okuda
      affiliation:
            name:Astellas Pharma. Inc.
            address:
               name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
               type:PostalAddress
            type:Organization
            name:Nemoto Science Co., Ltd
            address:
               name:Formulation, Tsukuba Laboratory, Nemoto Science Co., Ltd, Joso-shi, Japan
               type:PostalAddress
            type:Organization
      name:Kenichi Kakefuda
      affiliation:
            name:Astellas Pharma. Inc.
            address:
               name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
      name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
      name:Electronic Materials Department, Idemitsu Kosan Co., Ltd., Sodegaura, Japan
      name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
      name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
      name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
      name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
      name:X-Chem Inc., Waltham, USA
      name:X-Chem Inc., Waltham, USA
      name:X-Chem Inc., Waltham, USA
      name:Civetta Therapeutics, Cambridge, USA
      name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan
      name:Formulation, Tsukuba Laboratory, Nemoto Science Co., Ltd, Joso-shi, Japan
      name:Drug Discovery Research, Astellas Pharma. Inc., Tsukuba, Japan

Social Networks {👍}(1)

External Links {🔗}(170)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

4.89s.